Research output per year
Research output per year
Personal profile
Research interests
Heritable disorders of bone and mineral metabolism - including diagnosis, natural history, and treatment. Dysplastic skeletal diseases - including high bone mass, accelerated bone turnover, and osteolytic skeletal disease. Physiological role of alkaline phosphatase, osteoprotegerin, and RANK-Ligand action in bone biology.
Areas of Clinical Interest
Diagnosis and treatment of heritable disorders of bone and mineral metabolism, bone disease in adults and children, mineral disease, osteogenesis imperfecta, rickets, osteopetrosis, hypophosphatasia, hypophosphatemia, genetics, vitamin D-resistant rickets, metabolic and dysplastic bone disease in children, chondrodysplasia, pseudohypoparathyroidism, juvenile osteoporosis
Fingerprint
Dive into the research topics where Michael Whyte is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V
Whyte, M. P., Aronson, J., McAlister, W. H., Weinstein, R. S., Wenkert, D., Clements, K. L., Gottesman, G. S., Madson, K. L., Stolina, M., Bijanki, V. N., Plotkin, H., Huskey, M., Duan, S. & Mumm, S., Apr 2021, In: Bone. 145, 115835.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Non-endemic skeletal fluorosis: Causes and associated secondary hyperparathyroidism (case report and literature review)
Cook, F. J., Seagrove-Guffey, M., Mumm, S., Veis, D. J., McAlister, W. H., Bijanki, V. N., Wenkert, D. & Whyte, M. P., Apr 2021, In: Bone. 145, 115839.Research output: Contribution to journal › Article › peer-review
-
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Padidela, R., Whyte, M. P., Glorieux, F. H., Munns, C. F., Ward, L. M., Nilsson, O., Portale, A. A., Simmons, J. H., Namba, N., Cheong, H. I., Pitukcheewanont, P., Sochett, E., Högler, W., Muroya, K., Tanaka, H., Gottesman, G. S., Biggin, A., Perwad, F., Williams, A., Nixon, A. & 4 others, , May 2021, In: Calcified Tissue International. 108, 5, p. 622-633 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia
Seefried, L., Kishnani, P. S., Moseley, S., Denker, A. E., Watsky, E., Whyte, M. P. & Dahir, K. M., Jan 2021, In: Bone. 142, 115664.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Tumor-Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti-FGF23 Monoclonal Antibody
Whyte, M. P., Apr 2021, In: Journal of Bone and Mineral Research. 36, 4, p. 625-626 2 p.Research output: Contribution to journal › Editorial